Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7NFR

Fujian capmidlink domain in complex with Nb8194

Summary for 7NFR
Entry DOI10.2210/pdb7nfr/pdb
DescriptorPolymerase basic protein 2, NB8194, GLYCEROL, ... (5 entities in total)
Functional Keywordsinfluenza polymerase, cap-binding domain, nanobody, viral protein
Biological sourceInfluenza A virus (A/duck/Fujian/13/2002(H5N1))
More
Total number of polymer chains2
Total formula weight48898.02
Authors
Keown, J.R.,Grimes, J.M.,Fodor, E. (deposition date: 2021-02-07, release date: 2021-12-01, Last modification date: 2024-01-31)
Primary citationKeown, J.R.,Zhu, Z.,Carrique, L.,Fan, H.,Walker, A.P.,Serna Martin, I.,Pardon, E.,Steyaert, J.,Fodor, E.,Grimes, J.M.
Mapping inhibitory sites on the RNA polymerase of the 1918 pandemic influenza virus using nanobodies.
Nat Commun, 13:251-251, 2022
Cited by
PubMed Abstract: Influenza A viruses cause seasonal epidemics and global pandemics, representing a considerable burden to healthcare systems. Central to the replication cycle of influenza viruses is the viral RNA-dependent RNA polymerase which transcribes and replicates the viral RNA genome. The polymerase undergoes conformational rearrangements and interacts with viral and host proteins to perform these functions. Here we determine the structure of the 1918 influenza virus polymerase in transcriptase and replicase conformations using cryo-electron microscopy (cryo-EM). We then structurally and functionally characterise the binding of single-domain nanobodies to the polymerase of the 1918 pandemic influenza virus. Combining these functional and structural data we identify five sites on the polymerase which are sensitive to inhibition by nanobodies. We propose that the binding of nanobodies at these sites either prevents the polymerase from assuming particular functional conformations or interactions with viral or host factors. The polymerase is highly conserved across the influenza A subtypes, suggesting these sites as effective targets for potential influenza antiviral development.
PubMed: 35017564
DOI: 10.1038/s41467-021-27950-w
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.88 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon